Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation

By S. Iyer, Qiong He, J. R. Janczy, Eric I. Elliott, Zhenyu Zhong, A. Olivier, J. Sadler, Vickie Knepper-Adrian, Renzhi Han, L. Qiao and 4 more. Immunity, 2013

866 citations recorded by the source corpus.

Summary Nlrp3 inflammasome activation occurs in response to numerous agonists but the specific mechanism by which this takes place remains unclear. All previously evaluated activators of the Nlrp3 inflammasome induce the generation of mitochondrial reactive oxygen species (ROS), suggesting a model in which ROS is a required upstream mediator of Nlrp3 inflammasome activation. Here we have identified the oxazolidinone antibiotic, linezolid, as a Nlrp3 agonist that activates the Nlrp3 inflammasome independently of ROS. The pathways for ROS-dependent and ROS-independent Nlrp3 activation converged upon mitochondrial dysfunction and specifically the mitochondrial lipid cardiolipin. Cardiolipin bound to Nlrp3 directly and interference with cardiolipin synthesis specifically inhibited Nlrp3 inflammasome activation. Together these data suggest that mitochondria play a critical role in the activation of the Nlrp3 inflammasome through the direct binding of Nlrp3 to cardiolipin.

Subfields: Molecular Biology

View Paper: https://www.semanticscholar.org/paper/e804abc42b82bff8feadd384a07fae2d373e7a49

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

  1. T. Kanneganti
  2. Guido Kroemer
  3. L. Galluzzi
  4. Douglas R. Green
  5. M. Lamkanfi
  6. G. Núñez
  7. S. Man
  8. Yuan He

Citations in the corpus